Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2629 of 5804
-
Could a Two-Drug rescue inhaler cut asthma attacks?
Disease control OngoingANCHOR is a prospective, phase IV, interventional, single-arm, open-label study of 1,500 adult participants with symptomatic asthma requiring the use of rescue therapy aimed to compare the asthma exacerbation rates before and after switching from albuterol or levalbuterol to albu…
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
EATING YOUR WAY TO CLEARER SKIN? NEW STUDY TESTS DIET FOR ECZEMA
Symptom relief Recruiting nowDiet is a key determinant of overall health, with growing evidence associating dietary patterns with allergic diseases. Among these, atopic dermatitis (AD) is of particular interest as it often represents the earliest manifestation of the atopic triad. Investigating dietary inter…
Phase: NA • Sponsor: National University of Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Writing away trauma: group therapy shows promise for teens with PTSD
Symptom relief CompletedThe study aims to examine the effectiveness of group-delivered guided written exposure therapy (GWE) for post-traumatic stress disorder (PTSD) and complex PTSD in Chinese adolescents through a randomized controlled trial. A total of 50 participants will be recruited, with 25 rand…
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New hemophilia drug enters human safety trials
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) of SR604 in healthy participants (Part A) and to evaluate the safety, tolerability, PK, PD, and efficacy of SR604 in participants with Hemophilia A or Hemophilia B, …
Phase: PHASE1 • Sponsor: Equilibra Bioscience LLC • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
3D-Printed guides could sharpen wrist surgery for rare bone disease
Disease control Recruiting nowIschemic necrosis of lunate bone, osteonecrosis or Kienböck´s disease was described by Kienböck in 1910. Numerous surgical procedures for this disease had been proposed. These surgical options, that depends of the radiological stage and anatomical risk factors, can be classified …
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug SIBP-A13 enters human testing for hard-to-treat cancers
Disease control Recruiting nowTo evaluate the safety, tolerability, and pharmacokinetic characteristics of SIBP-A13 and determine the maximum tolerable dose (MTD) and phase II recommended dose (RP2D).
Phase: PHASE1 • Sponsor: Shanghai Institute Of Biological Products • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Sjögren's drug trial halted: what happened?
Disease control TerminatedThe purpose of this study is to measure the efficacy and safety of HZN-1116 in participants with Sjogren's syndrome (SS).
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New study tracks pain relief after ablation for abdominal wall endometriosis
Symptom relief ENROLLING_BY_INVITATIONTo determine the characteristics of recovery and symptom relief following ablation of abdominal wall endometriosis.
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New drug may help children with shock by fixing tiny blood vessels
Disease control CompletedThis prospective randomized controlled trial was designed to evaluate whether the M1/M3-selective antagonist penehyclidine hydrochloride could more effectively reverse pediatric microcirculatory dysfunction than traditional atropine, particularly when macrohemodynamics appear nor…
Phase: NA • Sponsor: Lihua Wen • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New blood test aims to catch bile duct cancer relapse early
Knowledge-focused ENROLLING_BY_INVITATIONThis study explores the potential value of a new blood test approach to detect measurable residual disease or early recurrence/progression in patients with cholangiocarcinoma.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Head-to-Head: which mood stabilizer works best for bipolar II?
Disease control Recruiting nowThe investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in patients with BDII.
Phase: PHASE4 • Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New eye drops aim to soothe blistering eye pain in rare skin disease
Symptom relief OngoingThis study consists of two phases: an Observational Phase to evaluate the natural history of ocular manifestations in subjects with Dystrophic and Junctional Epidermolysis Bullosa, followed by a Treatment Phase to assess the effects of ELK-003 eye drops. Each subject will serve a…
Phase: PHASE1 • Sponsor: Fundación DEBRA Chile, Niños Piel de Cristal • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Could common diabetes pills help Parkinson's and dementia?
Disease control CompletedThe purpose of this study is to test the hypothesis that DPP4 inhibitors and SGLT2 inhibitors are well tolerated and have beneficial neurological effects, specifically for Parkinson's disease and Lewy body dementia.
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New dream remote aims to banish Children's nightmares
Symptom relief OngoingThis clinical trial will test the efficacy of parent-delivered DreamChanger Intervention in combination with Imagery Rehearsal Therapy (IRT) for reducing the frequency and severity of nightmares in children aged 3-10. Children will be randoimized to either the combined interventi…
Phase: NA • Sponsor: Tel Aviv University • Aim: Symptom relief
Last updated Jun 26, 2026 18:39 UTC
-
Virus injection takes on Hard-to-Treat cancers in early trial
Disease control ENROLLING_BY_INVITATIONThis is a Phase 1 open-label study to evaluate the safety, tolerability, and pharmacokinetics of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) at dose of 5×10∧9VP、5×10∧10VP、5×10∧11VP in Patients With Malignant Solid Tumors. Subjects will be treated with a si…
Phase: PHASE1 • Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Major study tracks mitochondrial disease to unlock its secrets
Knowledge-focused Recruiting nowThe Natural History of Mitochondrial (MITO) Diseases (a longitudinal study observing the natural history of mitochondrial diseases) The goal of this observational study (non-randomised retrospective and prospective) is to fully characterise primary MITO disease; that includes bo…
Sponsor: Neuroscience Research Australia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Can extra salt calm racing hearts? new POTS study aims to find out
Symptom relief Recruiting nowMany patients with postural orthostatic tachycardia syndrome (POTS) have decreased plasma volume. Current POTS guidelines recommend \~10 g of salt and 2-3 L of fluid per day. Despite this recommendation, there is no long term data evaluating the use of salt in POTS. This randomiz…
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
App aims to shield kids from smoke at home
Prevention Recruiting nowUnrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCD…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Survivors' hidden toll: chest radiation linked to brain changes
Knowledge-focused Recruiting nowSURVIVORS Study participants are being asked to take part in this research study called HODNIRS because the participant is a survivor of Hodgkin Lymphoma (HL) treated with chest radiation and bleomycin at St. Jude Children's Research Hospital. The study is being done to help inv…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a brain ZAP boost thinking skills in severe mental illness?
Symptom relief OngoingSeven per cent of patients suffering from severe mental illness (SMI) need long-term intensive treatment and support in a clinical setting or sheltered living. These service users often experience problems on multiple domains, such as persistent complaints as a result of medicati…
Phase: NA • Sponsor: University of Groningen • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC